Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 1 800 FLOWERS COM INCFLWS · Entity 6237 | Chief Accounting Officer | September 11, 2026 | September 15, 2026 |
| HAIN CELESTIAL GROUP INCHAIN · Entity 7055 | SVP & Chief Accounting Officer | January 24, 2020 | January 28, 2020 |
| agilon health, inc.AGL · Entity 4698 | Chief Accounting Officer | April 14, 2023 | April 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
1 800 FLOWERS COM INC
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 154,354 |
Ending reported balance
After 2026-09-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-11 · Grant · Acquired 4,995 · Balance 124,109 Row 2 · 2026-09-11 · Grant · Acquired 30,245 · Balance 154,354 |
HAIN CELESTIAL GROUP INC
Report date January 24, 2020 · Filed January 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,020 |
Ending reported balance
After 2020-01-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-01-24 · Exercise / conversion · Acquired 780 · Balance 4,327 F1: On January 24, 2020, 780 restricted stock units ("RSUs") of The Hain Celestial Group, Inc. (the "Company") vested pursuant to the Restricted Stock Units Agreement between the Company and the Reporting Person (the "Agreement"), and upon such vesting the Reporting Person received 780 shares of common stock of the Company. Row 2 · 2020-01-24 · Tax withholding · Disposed 307 · Balance 4,020 F2: The Company retained 307 shares of common stock to satisfy the tax withholding obligations in connection with the vesting of 780 RSUs as required by the terms of the Agreement and consistent with the Company's practice for satisfying such U.S. tax withholding obligations. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,560 |
Reported balance
After 2020-01-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-01-24 · Exercise / conversion · Disposed 780 · Balance 1,560 F3: Each RSU represents a contingent right to receive one share of common stock of the Company. F4: Of the 2,340 RSUs granted, 33-1/3% vested on January 24, 2020 and 33-1/3% will vest on each of January 24, 2021 and 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 24, 2020, 780 restricted stock units ("RSUs") of The Hain Celestial Group, Inc. (the "Company") vested pursuant to the Restricted Stock Units Agreement between the Company and the Reporting Person (the "Agreement"), and upon such vesting the Reporting Person received 780 shares of common stock of the Company.
F2: The Company retained 307 shares of common stock to satisfy the tax withholding obligations in connection with the vesting of 780 RSUs as required by the terms of the Agreement and consistent with the Company's practice for satisfying such U.S. tax withholding obligations.
F3: Each RSU represents a contingent right to receive one share of common stock of the Company.
F4: Of the 2,340 RSUs granted, 33-1/3% vested on January 24, 2020 and 33-1/3% will vest on each of January 24, 2021 and 2022.
agilon health, inc.
Report date April 14, 2023 · Filed April 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,745 |
Reported balance
After 2023-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-04-14 · Grant · Acquired 4,393 · Balance 7,745 F1: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2: Includes restricted stock units. |
| Options (Rights to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.46 · Expires 2033-04-14 | Direct | 7,595 |
Reported balance
After 2023-04-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-04-14 · Grant · Acquired 7,595 · Balance 7,595 F3: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2: Includes restricted stock units.
F3: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EDGEWELL PERSONAL CARE Co
Report date August 26, 2022 · Filed August 29, 2022
Section 16 reporting ended · disclosed 2022-08-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Equivalent 1/4/2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-08-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-08-26 · Other · Disposed 3,473 · Balance 0 F1: Unvested award forfeited upon Ms. Kasenchak's departure from the Company on August 26, 2022. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2022-08-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested award forfeited upon Ms. Kasenchak's departure from the Company on August 26, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 15, 2026 16:44 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | GrantClass A Common Stock | 30,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-030416 · rdgdoc.xml · nonDerivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,354 Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 16:44 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | GrantClass A Common Stock | 4,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-030416 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,109 Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 12:52 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | Tax withholdingClass A Common Stock | 15,087 | $3.77 | $56,877.99 |
DisclosureSEC source: 0001437749-26-023109 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,114 F1 · shares: Transaction is a deemed disposition that is exempt under Section 16(b) of the Exchange Act consisting of the withholding for tax purposes of shares of Common Stock by the Company upon vesting of restricted shares of Common Stock. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 19:07 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | Tax withholdingClass A Common Stock | 1,440 | $4.30 | $6,192.00 |
DisclosureSEC source: 0001437749-25-037975 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,201 F1 · shares: Transaction is a deemed disposition that is exempt under Section 16(b) of the Exchange Act consisting of the withholding for tax purposes of shares of Common Stock by the Company upon vesting of restricted shares of Common Stock. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 16:19 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | GrantClass A Common Stock | 59,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037666 · rdgdoc.xml · nonDerivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,641 Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 16:19 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | GrantClass A Common Stock | 29,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037666 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,531 Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 16:25 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | Tax withholdingClass A Common Stock | 2,861 | $3.49 | $9,984.89 |
DisclosureSEC source: 0001437749-25-034015 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,976 F1 · shares: Transaction is a deemed disposition that is exempt under Section 16(b) of the Exchange Act consisting of the withholding for tax purposes of shares of Common Stock by the Company upon vesting of restricted shares of Common Stock. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 16:52 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | Tax withholdingClass A Common Stock | 1,622 | $3.49 | $5,660.78 |
DisclosureSEC source: 0001437749-25-033778 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,837 F1 · shares: Transaction is a deemed disposition that is exempt under Section 16(b) of the Exchange Act consisting of the withholding for tax purposes of shares of Common Stock by the Company upon vesting of restricted shares of Common Stock. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 19:45 UTC | 1 800 FLOWERS COM INC FLWS · Entity 6237 | GrantClass A Common Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-030852 · rdgdoc.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,459 Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 7,595 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024667 · doc4.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,595 Underlying: Common Stock · 7,595 shares Expires 2033-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 4,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024667 · doc4.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,745 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 5,413 | $0.00 Strike: $23.87 | $0.00 |
DisclosureSEC source: 0001209191-22-052868 · doc4.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,413 Underlying: Common Stock · 5,413 shares Expires 2032-10-03 F2 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. F2 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 3,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052868 · doc4.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,352 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. Read SEC document |
| August 26, 2022 Filed Aug 29, 2022 13:17 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalent 1/4/2022 · Derivative | 3,473 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047788 · doc4.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,473 shares Expires not disclosed F1 · derivative.exercise_date: Unvested award forfeited upon Ms. Kasenchak's departure from the Company on August 26, 2022. F1 · derivative.expiration_date: Unvested award forfeited upon Ms. Kasenchak's departure from the Company on August 26, 2022. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 18:43 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 1/4/2022 · Derivative | 3,473 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001510 · doc4.xml · derivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,473 Underlying: Common Stock · 3,473 shares Expires 2032-01-04 F1 · derivative.exercise_date: The RSEs will vest and convert into shares of Edgewell common stock on 1/4/2024 if the Reporting Person is employed on said date, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:18 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | Exercise / conversionRestricted Stock Units · Derivative | 780 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-20-000002 · wf-form4_158024626344465.xml · derivative · entry 3 Kasenchak Priscilla · CIK 0001793048 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560 Underlying: Common Stock · 780 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: Of the 2,340 RSUs granted, 33-1/3% vested on January 24, 2020 and 33-1/3% will vest on each of January 24, 2021 and 2022. F4 · derivative.expiration_date: Of the 2,340 RSUs granted, 33-1/3% vested on January 24, 2020 and 33-1/3% will vest on each of January 24, 2021 and 2022. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:18 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | Tax withholdingCommon Stock | 307 | $24.96 | $7,662.72 |
DisclosureSEC source: 0000910406-20-000002 · wf-form4_158024626344465.xml · nonDerivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,020 F2 · kind: The Company retained 307 shares of common stock to satisfy the tax withholding obligations in connection with the vesting of 780 RSUs as required by the terms of the Agreement and consistent with the Company's practice for satisfying such U.S. tax withholding obligations. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:18 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | Exercise / conversionCommon Stock | 780 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-20-000002 · wf-form4_158024626344465.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 24, 2020, 780 restricted stock units ("RSUs") of The Hain Celestial Group, Inc. (the "Company") vested pursuant to the Restricted Stock Units Agreement between the Company and the Reporting Person (the "Agreement"), and upon such vesting the Reporting Person received 780 shares of common stock of the Company. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:08 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantRestricted Stock Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-19-000136 · wf-form4_157661689032337.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 Underlying: Common Stock · 1,898 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: These RSUs will vest in three (3) equal installments on November 1, 2020, 2021 and 2022. F4 · derivative.expiration_date: These RSUs will vest in three (3) equal installments on November 1, 2020, 2021 and 2022. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:08 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantPerformance Based Restricted Stock Units · Derivative | 6,614 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-19-000136 · wf-form4_157661689032337.xml · derivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,271 Underlying: Common Stock · 6,614 shares Expires not disclosed F1 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of common stock of The Hain Celestial Group, Inc. (the "Company"). F2 · derivative.exercise_date: These PSUs are subject to both performance and time vesting requirements. The number of PSUs reported represents the target number of PSUs under the award. The number of PSUs that vest, if any, may vary from 0% to 300% of the target number shown, and is based on criteria related to the annual total shareholder return of the Company over the three-year period beginning on November 6, 2018. The time vesting requirement will be satisfied on November 6, 2021. F2 · derivative.expiration_date: These PSUs are subject to both performance and time vesting requirements. The number of PSUs reported represents the target number of PSUs under the award. The number of PSUs that vest, if any, may vary from 0% to 300% of the target number shown, and is based on criteria related to the annual total shareholder return of the Company over the three-year period beginning on November 6, 2018. The time vesting requirement will be satisfied on November 6, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.